An Open Label Randomized Controlled Trial of Ivermectin Plus Favipiravir-Based Standard of Care versus Favipiravir-Based Standard of Care for Treatment of Moderate COVID-19 in Thailand
Sarojvisut et al., Infection & Chemotherapy, doi:10.3947/ic.2022.0127
https://c19ivm.org/sarojvisut.html